Daniela Alves da Quinta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniela Alves da Quinta has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Daneri-Navarro
Instituto de Investigación en Inmunología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Mexico
9 shared publications - Alejandra Lopez-Vazquez
Universidad de Sonora, Hermosillo, México
9 shared publications - Alicia Del Toro-Arreola
Laboratorio de Inmunología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico
9 shared publications - Andrea Sabina Llera
Fundación Instituto Leloir-CONICET, Buenos Aires, Argentina
9 shared publications - Antonio Quintero-Ramos
Instituto Mexicano del Seguro Social, Centro Médico Nacional de Occidente, Hospital de Especialidades, Unidad de Investigación Biomédica 02. Guadalajara, Jalisco, México Instituto Mexicano del Seguro Social México
9 shared publications - Bettina Müller
Chilean Cooperative Group for Oncological Research (GOCCHI), Santiago, Chile
9 shared publications
Latest Publications
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Table 3 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Univariate and multivariate Cox proportional hazard models for overall survival for every 10% increase of EUR or IA ancestry
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable 3 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Univariate and multivariate Cox proportional hazard models for overall survival for every 10% increase of EUR or IA ancestry
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Figure 1 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Population structure of the 951 patients with breast cancer of the LACRN-MPBCS cohort included in this study. A, ADMIXTURE ancestry estimations obtained assuming four ancestral components for each country of origin (B) Principal component analysis (PCA) of data from all LACRN-MPBCS patients (triangles) and 158 reference subjects (dots). The two principal components of variation are shown as PC1 and PC2. C and D, Boxplots showing the distribution of each ancestry component for the whole cohort and by country, respectively. Median ancestry and IQRs are depicted; whiskers extend up to 1.5 IQR. Values outside the inter-quartile range are shown as solid dots. AFR, African; EAS, East Asian; EUR, European; IA, Indigenous American.
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 1 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Population structure of the 951 patients with breast cancer of the LACRN-MPBCS cohort included in this study. A, ADMIXTURE ancestry estimations obtained assuming four ancestral components for each country of origin (B) Principal component analysis (PCA) of data from all LACRN-MPBCS patients (triangles) and 158 reference subjects (dots). The two principal components of variation are shown as PC1 and PC2. C and D, Boxplots showing the distribution of each ancestry component for the whole cohort and by country, respectively. Median ancestry and IQRs are depicted; whiskers extend up to 1.5 IQR. Values outside the inter-quartile range are shown as solid dots. AFR, African; EAS, East Asian; EUR, European; IA, Indigenous American.
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Information from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Supplementary information and List of LACRN Investigators
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Information from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Supplementary information and List of LACRN Investigators
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Table 2 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Association between HER2 status, IHC and PAM50 subtypes, and EUR genetic ancestry (for every 10% increase in EUR or IA ancestry component)
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable 2 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Association between HER2 status, IHC and PAM50 subtypes, and EUR genetic ancestry (for every 10% increase in EUR or IA ancestry component)
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Distribution of immunohistochemistry (IHC) breast cancer subtypes according to the four most prevalent ancestral components in Latin America.
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Distribution of immunohistochemistry (IHC) breast cancer subtypes according to the four most prevalent ancestral components in Latin America.
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Table 1 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
By-country epidemiologic and clinical characteristics of the 951 patients of the LACRN-MPBCS included in this study
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable 1 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
By-country epidemiologic and clinical characteristics of the 951 patients of the LACRN-MPBCS included in this study
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Distribution of the four ancestries (rows) according to the MPBCS participating institutions in each LACRN country (columns).
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Distribution of the four ancestries (rows) according to the MPBCS participating institutions in each LACRN country (columns).
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Figure 2 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Distribution of PAM50 breast cancer subtypes according to the four most prevalent ancestral components in Latin America: European (EUR), Indigenous American (IA), African (AFR), and East Asian (EAS). Bars shown correspond to post hoc Dunn test pairwise comparisons <0.05. HER2E, HER2-enriched; LumA, luminal A; LumB, luminal B.
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 2 from Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Distribution of PAM50 breast cancer subtypes according to the four most prevalent ancestral components in Latin America: European (EUR), Indigenous American (IA), African (AFR), and East Asian (EAS). Bars shown correspond to post hoc Dunn test pairwise comparisons <0.05. HER2E, HER2-enriched; LumA, luminal A; LumB, luminal B.
- Open Access
- 1 July 2025
- Published by American Association for Cancer Research (AACR) in Cancer Research Communications
- Vol. 5 (7) , 1070-1081
Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
This study investigates the relationship between genetic ancestry, breast cancer subtypes, and survival outcomes among 951 locally advanced breast cancer cases from Argentina, Brazil, Chile, Mexico, and Uruguay, participating in the Molecular Profile of Breast Cancer Study. Array-based genotyping and ADMIXTURE analysis were used for genetic ancestry evaluation. Breast cancer subtypes were defined by IHC and the gene expression–based PAM50 algorithm. The distribution of genetic ancestry, including European, Indigenous American (IA), African (AFR), and East Asian components, revealed a heterogeneous genetic admixture across countries, with the highest IA ancestry observed in Chile (30.9%) and Mexico (30.8%). Testing the relationship between genetic ancestry and breast cancer subtypes demonstrated that a 10% increase in European ancestry was significantly associated with a 14% decrease in the odds of developing HER2-enriched breast cancer, after adjustment by age, nodal status, and the AFR component (adj. P = 0.021, luminal A as reference). Accordingly, a 10% increase in IA ancestry was associated with a 21% increase in the probability of having HER2-enriched breast cancer (adj. P = 0.022). IA ancestry also significantly increased overall survival after adjustment by age, nodal status, and AFR ancestry, although this result is controversial and may be affected by the size and heterogeneity of the Molecular Profile Breast Cancer Study cohort. Our research confirms previous findings of a high prevalence of HER2-dependent breast tumors among Hispanic/Latina women and strengthens the hypotheses of the existence of either population-specific genetic variant(s) or of other ancestry-correlated factors that impact HER2 expression in breast cancer consistently across different Latin American regions. Significance: The evidence in this work supports the idea that factors linked to genetic ancestry influence the prevalence of breast cancer subtypes in Latin America, potentially affecting treatment needs in the region.
- 1 July 2025
- Published by American Association for Cancer Research (AACR) in Cancer Research Communications
- Vol. 5 (7) , 1070-1081
Open AccessGenetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
This study investigates the relationship between genetic ancestry, breast cancer subtypes, and survival outcomes among 951 locally advanced breast cancer cases from Argentina, Brazil, Chile, Mexico, and Uruguay, participating in the Molecular Profile of Breast Cancer Study. Array-based genotyping and ADMIXTURE analysis were used for genetic ancestry evaluation. Breast cancer subtypes were defined by IHC and the gene expression–based PAM50 algorithm. The distribution of genetic ancestry, including European, Indigenous American (IA), African (AFR), and East Asian components, revealed a heterogeneous genetic admixture across countries, with the highest IA ancestry observed in Chile (30.9%) and Mexico (30.8%). Testing the relationship between genetic ancestry and breast cancer subtypes demonstrated that a 10% increase in European ancestry was significantly associated with a 14% decrease in the odds of developing HER2-enriched breast cancer, after adjustment by age, nodal status, and the AFR component (adj. P = 0.021, luminal A as reference). Accordingly, a 10% increase in IA ancestry was associated with a 21% increase in the probability of having HER2-enriched breast cancer (adj. P = 0.022). IA ancestry also significantly increased overall survival after adjustment by age, nodal status, and AFR ancestry, although this result is controversial and may be affected by the size and heterogeneity of the Molecular Profile Breast Cancer Study cohort. Our research confirms previous findings of a high prevalence of HER2-dependent breast tumors among Hispanic/Latina women and strengthens the hypotheses of the existence of either population-specific genetic variant(s) or of other ancestry-correlated factors that impact HER2 expression in breast cancer consistently across different Latin American regions. Significance: The evidence in this work supports the idea that factors linked to genetic ancestry influence the prevalence of breast cancer subtypes in Latin America, potentially affecting treatment needs in the region.